Olga T. Filippova

Olga T. Filippova

Oncology

111 East 57th Street
Suite 3.4
New York, NY 10022

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Expanded subtype testing for circulating tumor HPV DNA reliably detects the presence of advanced-stage cervical cancer.

Expanded subtype testing for circulating tumor HPV DNA reliably detects the presence of advanced-stage cervical cancer.

Journal: Gynecologic oncology

Published: January 19, 2026

A prospective comparison of resectability scores to enhance preoperative decision-making in the primary management of advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary study.

A prospective comparison of resectability scores to enhance preoperative decision-making in the primary management of advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 16, 2025

A Feasibility Study for Mapping Ovarian Sentinel Lymph Nodes: A Memorial Sloan Kettering Cancer Center Team Ovary Study.

A Feasibility Study for Mapping Ovarian Sentinel Lymph Nodes: A Memorial Sloan Kettering Cancer Center Team Ovary Study.

Journal: Obstetrics and gynecology

Published: April 01, 2025

Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva.

Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: December 04, 2024

Five-year quality-of-life assessment by urinary diversion type after pelvic Exenterations.

Five-year quality-of-life assessment by urinary diversion type after pelvic Exenterations.

Journal: Gynecologic oncology

Published: September 04, 2024

Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study.

Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study.

Journal: Gynecologic oncology

Published: December 15, 2023

Isolated vaginal recurrence in women with stage I endometrial cancer.

Isolated vaginal recurrence in women with stage I endometrial cancer.

Journal: Gynecologic oncology

Published: May 22, 2023

Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.

Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.

Journal: Gynecologic oncology

Published: October 25, 2022

A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.

A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.

Journal: Gynecologic oncology

Published: June 15, 2022

Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents.

Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 08, 2022

Pattern of disease and response to pembrolizumab in recurrent cervical cancer.

Pattern of disease and response to pembrolizumab in recurrent cervical cancer.

Journal: Gynecologic oncology reports

Published: May 21, 2021

Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.

Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.

Journal: Gynecologic oncology

Published: April 08, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026